Carmignac

Carmignac Portfolio Human Xperience: Letter from the Fund Manager

  • Published
  • Length
    5 minute(s) read
  • +8.47%

    Carmignac Portfolio Human Xperience’s performance in the 1st quarter of 2023 for the A EUR Share class

  • +5.41%

    Reference indicator’s performance in the 1st quarter of 2023 for MSCI ACWI

Carmignac Portfolio Human Xperience is a thematic global equity fund invested in companies that demonstrate strong customer and employee experience. This strategy is sector and region agnostic as it seeks to select best-in-class companies with attractive scores based on our proprietary database. The fund aims to outperform its benchmark over five years and is designed for investors looking to have a positive impact on society.

During the first quarter of 2023, the return of Carmignac Portfolio Human Xperience was 8.47%. This compares to a return on the funds reference indicator1 of 5.41% over the same period.

Quarterly Performance Review

Global equity markets performed well in the quarter, driven, initially, by increased confidence in the economic outlook for the year, due to resilient consumer spending in US, falling energy prices in Europe and excitement at the prospect of China re-opening from lockdowns. Expectations of falling headline inflation were also positive as that would imply the worst of the interest rate rises is behind us. In March however, sentiment was dented by the collapse of three US banks and the forced acquisition of Credit Suisse by UBS, as tightening financial conditions start to take their toll. Although the market recovered as the month progressed, this was led by the less economically sensitive names reflecting heightened concern over the future trajectory of economic growth and corporate profit growth in second half 2023 and into 2024.

The market rally was led by the information technology sector, where whilst we typically only find modest exposure within our investible universe, we have significant exposure within the fund. Nvidia and Salesforce both rose +86% and +48% respectively as both had stellar quarters. Nvidia rose after full year results confirmed that the company is over the inventory correction and guidance implied an inflecting trajectory in demand in datacenter and gaming chips. Furthermore, the stock is the name most likely to benefit from the explosion in demand caused by progress in artificial intelligence (AI) through ChatGPT, as the number of graphics chips (GPUs) required will accelerate dramatically. Nvidia has a Carmignac Human Xperience score of 2 out of 100 highlighting both its strong customer and employee credentials e.g. from an employee perspective it is featured highly on both the Forbes, Fortune and Glassdoor top employer lists. Despite this we took the opportunity to trim the position. Salesforce which has a Carmignac Human Xperience score of 5 remains one of our long-term high conviction names. We increased our holding into their Q4 results on the belief that investors were underestimating their ability to improve and maintain their margins. They subsequently delivered a beat across the board with raised EBIT margin guidance for both 2023 and 2024.

The consumer sector was also a strong contributor over the quarter. The best holding within the fund in the period was cosmetics company L’Oreal, the parent company of the highly rated skincare company CeraVe rising +23%, and luxury company LVMH the owner of watch company Tag Heuer rising +24%. These names benefited from several factors: strong earnings reports for the final quarter of 2022, a less bleak outlook for consumers worldwide than thought several months ago as recession risks have abated, but also expectations that they will be prime beneficiaries of the reopening of the Chinese market. We believe this is a macro trend that will have continued tailwinds as from a macro perspective reduced inflationary pressures and stabilising interest rates vs. 2022 mean that there will potentially more money in consumers pockets in both 2023 and 2024. We believe that outside of the names mentioned above the likes of Adidas and Puma could be the biggest beneficiaries.

In terms of general activity, it was a very active quarter for the fund. We exited Block and Lululemon as both have Carmignac Human Xperience scores which had deteriorated enough that they no longer met the criteria of the fund (CHX scores > 30). We also exited Mercedes-Benz despite it having good long-term prospects from a Human Xperience perspective. Our fundamental view of the automobile sector turned more cautious as the announced price cuts from competitor Tesla put the pricing power and the margin story of Mercedes at risk. We started new positions in both Home Depot and Sony Group reinforcing our belief in the consumer led recovery for the inflation crisis of 2022 and also Intel which we see as one of the very few economic cyclicals which has seen a significant reduction in earnings expectations, hence a somewhat favourable risk reward profile.

Fund Positioning

We ended the quarter with 40% of the fund in both Consumer Discretionary and Consumer Staples stocks giving us a balance exposure to the consumer, with the more cyclical names to take advantage of an improving/less painful inflationary backdrop for consumers. Our Technology exposure at 34% is in-line with our long term held belief that these are some of the best companies when it comes to creating both product that people want and will be prepared to pay a premium for whilst doing their best to maintain their competitive advantage by retaining the best talent in the marketplace.

Outlook

We continue to remain underweight some of the most economically sensitive sectors such as Energy, Materials, Industrials and Financials/Banks as the opportunity set remains very narrow especially when it comes to the customer satisfaction component and in the case of the latter sector Financials/Banks this proved to have been a helpful contributor to performance in Q1.

1MSCI ACWI (USD) (Reinvested net dividends). Performance of the A EUR acc share class. Past performance is not a reliable indicator of future performance. The return may increase or decrease as a result of currency fluctuations. Performances are net of fees (excluding possible entrance fees charged by the distributor).

Carmignac Portfolio Human Xperience

A thematic fund focused on customer and employee experience

Discover the fund page

Carmignac Portfolio Human Xperience A EUR Acc

ISIN: LU2295992163

Recommended minimum investment horizon

Lower risk Higher risk

1 2 3 4 5 6 7
Main risk of the Fund

EQUITY: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.

CURRENCY: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.

DISCRETIONARY MANAGEMENT: Anticipations of financial market changes made by the Management Company have a direct effect on the Fund's performance, which depends on the stocks selected.

The Fund presents a risk of loss of capital.

Carmignac Portfolio Human Xperience A EUR Acc

ISIN: LU2295992163
2019 2020 2021 2022 2023 2024 (YTD)
?
Year to date
Carmignac Portfolio Human Xperience A EUR Acc - - +19.24 % -21.82 % +22.62 % +6.91 %
Reference Indicator - - +17.15 % -13.01 % +18.06 % +7.08 %

Scroll right to see full table

3 Years 5 Years 10 Years
Carmignac Portfolio Human Xperience A EUR Acc - - -
Reference Indicator - - -

Scroll right to see full table

Source : Carmignac at 29/02/2024

Entry costs : 4,00% of the amount you pay in when entering this investment. This is the most you will be charged. Carmignac Gestion doesn't charge any entry fee. The person selling you the product will inform you of the actual charge.
Exit costs : We do not charge an exit fee for this product.
Management fees and other administrative or operating costs : 1,80% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees : 20,00% when the share class overperforms the Reference indicator during the performance period. It will be payable also in case the share class has overperformed the reference indicator but had a negative performance. Underperformance is clawed back for 5 years. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost : 0,26% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.co.uk, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.